Portage Biotech Inc. (PRTG)
NASDAQ: PRTG
· Real-Time Price · USD
8.44
-0.24 (-2.76%)
At close: Aug 18, 2025, 10:33 AM
Portage Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -1.36M | -1.66M | -24.89M | -39.37M | -5.16M | -5.93M | -94.45M | -7.5M | -1.08M | -1.63M | -8.86M | -4.21M | -2.88M | -3.22M | -11.5M | -1.18M | -2.46M | -696K |
Depreciation & Amortization | 7K | 8K | 13K | 15K | 15K | 11K | 108.58M | 1K | n/a | n/a | n/a | -81K | 43K | -325K | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 141K | 144K | 389K | 736K | 743K | 769K | 662K | 1.21M | 1.23M | 1.18M | 2.7M | 2.11M | 2.15M | 2.18M | 8.12M | 200K | 237K | 296K |
Other Working Capital | -116K | 166K | 225.61K | -433.34K | 504.81K | 667K | -1.35M | 711K | -120K | 780K | -669K | -32K | -134K | 2K | 431K | -100K | -1.02M | 55K |
Other Non-Cash Items | -230K | -1.15M | 21.58M | 44.83M | 160.56K | 1.19M | -3.11M | 633K | 16K | 89K | -365.01K | 30K | 30K | 30K | -384.8K | 213.87K | 278K | -343K |
Deferred Income Tax | n/a | n/a | n/a | -9.41M | -915.71K | -148K | -14.95M | 2.17M | -2.55M | -2.55M | 4.84M | 92K | -657K | 121K | 2.55M | n/a | n/a | n/a |
Change in Working Capital | -116K | 968K | -302.29K | -223.64K | 858K | 650K | -1.41M | 775K | -115K | 736K | -532K | 394K | 40K | -363K | 297K | -84K | 55K | 55K |
Operating Cash Flow | -1.56M | -1.69M | -3.21M | -3.43M | -4.3M | -3.45M | -4.68M | -2.7M | -2.51M | -2.18M | -2.22M | -1.66M | -1.27M | -1.58M | -917K | -854.13K | -1.89M | -688K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -43.5 | 75.61 | -2.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.27K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 2.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.58K | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -8.9K | 15.47K | -607.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 140K | n/a |
Investing Cash Flow | n/a | n/a | 2.81M | n/a | n/a | n/a | -8.95K | 15.55K | -610.2K | n/a | n/a | n/a | n/a | n/a | -9.7K | n/a | 140K | -1M |
Debt Repayment | -10K | -9K | -12K | -11K | -10K | -7K | n/a | n/a | -2M | n/a | n/a | n/a | n/a | n/a | 50K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 1K | -5.29M | 5.34M | -1K | -19K | -66K | -24K | -1.01M | n/a | n/a | n/a | -81K | -1.67M | n/a | n/a | -2.15M | -248K |
Financial Cash Flow | -10K | -8K | 45.52K | 5.33M | 39K | 606K | 2.12M | 770K | -3.01M | n/a | -56.59K | 126.32K | -81K | 27.43M | 50K | n/a | -2.02M | 6.73M |
Net Cash Flow | -1.57M | -1.69M | -313K | 1.9M | -4.25M | -2.85M | -2.56M | -1.93M | -6.14M | -2.18M | -2.25M | -1.66M | -1.36M | 25.85M | -867K | -794K | -3.77M | 5.04M |
Free Cash Flow | -1.56M | -1.69M | -3.21M | -3.33M | -4.3M | -3.45M | -4.68M | -2.7M | -2.51M | -2.18M | -2.25M | -1.66M | -1.27M | -1.58M | -917K | -794K | -1.89M | -688K |